BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 32528461)

  • 1. Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis.
    Isopi E; Mattoscio D; Codagnone M; Mari VC; Lamolinara A; Patruno S; D'Aurora M; Cianci E; Nespoli A; Franchi S; Gatta V; Dubourdeau M; Moretti P; Di Sabatino M; Iezzi M; Romano M; Recchiuti A
    Front Immunol; 2020; 11():581. PubMed ID: 32528461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages.
    Recchiuti A; Patruno S; Mattoscio D; Isopi E; Pomilio A; Lamolinara A; Iezzi M; Pecce R; Romano M
    FASEB J; 2021 Apr; 35(4):e21441. PubMed ID: 33749902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection.
    Codagnone M; Cianci E; Lamolinara A; Mari VC; Nespoli A; Isopi E; Mattoscio D; Arita M; Bragonzi A; Iezzi M; Romano M; Recchiuti A
    Mucosal Immunol; 2018 Jan; 11(1):35-49. PubMed ID: 28422188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation.
    Abdulnour RE; Sham HP; Douda DN; Colas RA; Dalli J; Bai Y; Ai X; Serhan CN; Levy BD
    Mucosal Immunol; 2016 Sep; 9(5):1278-87. PubMed ID: 26647716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease.
    Ferri G; Serano M; Isopi E; Mucci M; Mattoscio D; Pecce R; Protasi F; Mall MA; Romano M; Recchiuti A
    FASEB J; 2023 Nov; 37(11):e23233. PubMed ID: 37823221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis.
    Eickmeier O; Fussbroich D; Mueller K; Serve F; Smaczny C; Zielen S; Schubert R
    PLoS One; 2017; 12(2):e0171249. PubMed ID: 28158236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
    Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
    Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolvin D1 regulates epithelial ion transport and inflammation in cystic fibrosis airways.
    Ringholz FC; Higgins G; Hatton A; Sassi A; Moukachar A; Fustero-Torre C; Hollenhorst M; Sermet-Gaudelus I; Harvey BJ; McNally P; Urbach V
    J Cyst Fibros; 2018 Sep; 17(5):607-615. PubMed ID: 29233471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis.
    Entezari M; Weiss DJ; Sitapara R; Whittaker L; Wargo MJ; Li J; Wang H; Yang H; Sharma L; Phan BD; Javdan M; Chavan SS; Miller EJ; Tracey KJ; Mantell LL
    Mol Med; 2012 May; 18(1):477-85. PubMed ID: 22314397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15-Epi-LXA
    Sekheri M; El Kebir D; Edner N; Filep JG
    Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7971-7980. PubMed ID: 32205444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages.
    Recchiuti A; Codagnone M; Pierdomenico AM; Rossi C; Mari VC; Cianci E; Simiele F; Gatta V; Romano M
    FASEB J; 2014 Jul; 28(7):3090-102. PubMed ID: 24692596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent.
    Orr SK; Colas RA; Dalli J; Chiang N; Serhan CN
    Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(9):L904-11. PubMed ID: 25770181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation.
    Saadane A; Soltys J; Berger M
    J Allergy Clin Immunol; 2006 May; 117(5):1163-9. PubMed ID: 16675347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.
    Stotland PK; Radzioch D; Stevenson MM
    Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation.
    Hsiao HM; Sapinoro RE; Thatcher TH; Croasdell A; Levy EP; Fulton RA; Olsen KC; Pollock SJ; Serhan CN; Phipps RP; Sime PJ
    PLoS One; 2013; 8(3):e58258. PubMed ID: 23484005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.
    Bensman TJ; Jayne JG; Sun M; Kimura E; Meinert J; Wang JC; Schaal JB; Tran D; Rao AP; Akbari O; Selsted ME; Beringer PM
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-Expressed p21/waf1 Favors Inflammation Resolution in Pseudomonas aeruginosa Infection.
    Martin C; Ohayon D; Alkan M; Mocek J; Pederzoli-Ribeil M; Candalh C; Thevenot G; Millet A; Tamassia N; Cassatella MA; Thieblemont N; Burgel PR; Witko-Sarsat V
    Am J Respir Cell Mol Biol; 2016 May; 54(5):740-50. PubMed ID: 26517580
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Brao KJ; Wille BP; Lieberman J; Ernst RK; Shirtliff ME; Harro JM
    Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32631918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.
    Cigana C; Curcurù L; Leone MR; Ieranò T; Lorè NI; Bianconi I; Silipo A; Cozzolino F; Lanzetta R; Molinaro A; Bernardini ML; Bragonzi A
    PLoS One; 2009 Dec; 4(12):e8439. PubMed ID: 20037649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
    Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
    Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.